Printer Friendly
The Free Library
14,679,458 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Stratagene to Present at the 2004 UBS Global Life Sciences Conference.


LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif. -- Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of life science research and diagnostic products, today announced that it will present at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Global Life Sciences Conference in New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 on Tuesday, September 28, 2004 at 1:00 p.m. Eastern Time. The presentation will include a review of the company's business strategy and historical financial results.

A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Stratagene's website at www.stratagene.com. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days and may be accessed at www.stratagene.com.

About Stratagene Corporation

Stratagene is a developer, marketer and manufacturer of life science research and diagnostic products. The Company's life science research operations support advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research. These products are used throughout the academic, industrial, and government research sectors in fields spanning molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller , genomics, proteomics, drug discovery and toxicology. The Company's diagnostic operations develop and manufacture products for urinalysis, and high quality automated instrument and reagent systems that use blood samples to test for more than 1000 different allergies and autoimmune disorders Autoimmune Disorders Definition

Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction.
. By combining Stratagene's expertise in diagnostics and molecular biology, as well as its experience with FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 regulatory procedures, the Company is pursuing opportunities to expand its product portfolio to include molecular diagnostics kits and instrumentation.

More information is available at http://www.stratagene.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 16, 2004
Words:269
Previous Article:EarthShell Provides Update on DTE Equipment Purchase Order and MBS Facility.
Next Article:George Risk Industries, Inc. First Quarter Results.



Related Articles
Stratagene Announces New National Market Listing.
Stratagene Announces First Quarter 2004 Earnings Release Date and Conference Call.
Stratagene Corp. Reports First Quarter Results for Stand-Alone Stratagene Operations; Year-Over-Year Revenue Up 15%; Net Income Grows 63%.
Stratagene Provides Preliminary Second Quarter Revenue Forecast and Schedules Release of Q2 Results; Company to Present at Baird's 2004 Small Cap...
Stratagene Announces Third Quarter 2004 Earnings Release Date and Conference Call.
Stratagene Revenue Grows 37% in Third Quarter; Strong Growth in QPCR, Mutagenesis and Allergy Clinical Diagnostics Product Lines EPS of $0.10.
Stratagene Announces Fourth Quarter and Full Year 2004 Earnings Release Date and Conference Call.
Stratagene to Present at the Banc of America 2005 Health Care Conference.
Stratagene to Present at the UBS Global Life Sciences Conference.
Stratagene to Present at the UBS Global Life Sciences Conference.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles